Sandoz launches EpiPen rival at $250 per two-pack

Sandoz launches EpiPen rival at $250 per two-pack

Source: 
BioPharma Dive
snippet: 

Sandoz has launched its epinephrine injection Symjepi, which the Swiss pharma argues will be an affordable alternative to existing epinephrine auto-injectors.